RECENT NEWS

HORIBA UK will be marking its 70th anniversary at IBMS Congress later this month, where delegates are invited to join the celebrations and also to see the company’s newly launched fully automated haemostasis analysers.

Doris-Ann Williams has retired from her role as Chief Executive at BIVDA, after almost 22 years.

Digital pathology firm Paige has joined forces with Microsoft, with the two firms working to transform cancer diagnosis and patient care by building the world’s largest image-based artificial intelligence (AI) models for digital pathology and oncology.

UK scientists will have access to the world’s largest research collaboration programme, Horizon Europe, after the Prime Minister Rishi Sunak secured a bespoke deal with improved financial terms for the UK’s participation.

Ibex Medical Analytics (Ibex), which is innovating AI-powered cancer diagnostics, has announced it has closed a $55 million Series C financing round led by 83North. Additional participants in the round were Sienna Venture Capital and existing investors in the company, Octopus Ventures, aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital. The financing brings total funding to over $100 million since Ibex’s inception in 2016.

The Institute of Biomedical Science (IBMS) has collaborated with Microsoft to publish a new white paper, ‘Digital Pathology and Integrated Care Systems: Enabling high-quality, equitable digital pathology services across networks, ICSs and nationally.’

BIOHIT HealthCare will be attending IBMS Congress 2023, where the company will showcase its new GastroPanel Quick Test for triaging gastroscopy referrals.

Quest Diagnostics has announced that its AAVrh74 ELISA (CDx) has been granted Breakthrough Device Designation from the US Food and Drug Administration (FDA).

Innovators seeking to bring their products to the NHS are still facing a lengthy and complex process, says the Medical Technology Group (MTG) in its latest 'Deja Review' report, with patients and clinicians missing out on the benefits provided by medical technology.

Scarborough Hospital in North Yorkshire is the latest institute affected by aerated concrete, with pathology staff currently being relocated to other parts of the building.

Molecular diagnostics group Yourgene Health has launched its new MagBench automated DNA extraction instrument and kit. MagBench offers a simple, fast and cost-efficient bench-top robotic cell-free DNA (cfDNA) extraction workstation optimised for Yourgene’s Sage 32 non-invasive prenatal testing (NIPT) workflow.

DoMore Diagnostics, a leader in deep learning precision diagnostics for digital pathology, and digital pathology provider Proscia have partnered to help pathologists predict outcomes for colorectal cancer (CRC) patients. The collaboration paves the way for integrating artificial intelligence (AI)-powered clinical decision support into routine pathology workflows.

IdentifySensors Biologics, a leading developer of digital diagnostic technologies, has partnered with Atlanta-based East West Manufacturing to produce medical diagnostic devices intended to rapidly detect and differentiate multiple infections from a single saliva sample.

Bio-Rad Laboratories has announced the launch of the 29th StarBright dye, StarBright Red 670, and an expansion of its current range with 29 additional highly validated antibodies conjugated to StarBright Blue 700 and StarBright Violet 610 dyes.

Global science firm Danaher has announced that it has entered into a definitive agreement to acquire Abcam, a leading global supplier to research scientists for approximately $5.7 billion.

The Medicines and Healthcare products Regulatory Agency (MHRA) has designated three new UK Approved Bodies, almost doubling the UK’s capacity to certify medical devices, supporting faster certification of safe and effective medical devices for healthcare professionals and the public.

Thermo Fisher Scientific has announced the commercial launch of its new EXENT Solution, after receiving IVDR certification. The EXENT solution is a fully integrated and automated mass spectrometry system designed to transform diagnosis and assessment for patients with monoclonal gammopathies, including multiple myeloma.

Diagnostics provider SYNLAB has set out its ambition to become the UK’s leading laboratory diagnostics organisation by 2027. It has unveiled a new vision, purpose and values which set a clear direction for the continued growth and success of each of its services in the UK – The Christie Pathology Partnership, Pathology First, Southwest Pathology Services, Synnovis, Lextox and SYNLAB Laboratory Services.

The Royal College of Pathologists (RCPath), the Institute of Biomedical Science (IBMS) and British Association for Cytopathology (BAC) have released a joint statement to guide the delivery of diagnostic cytopathology services across England.

The Royal College of Pathologists (RCPath) and the IBMS are jointly hosting the 2023 RCPath/IBMS Northern Symposium: Pathology and People. Taking place on 18 October at Cloth Hall Court, Leeds; the event will offer an exciting opportunity to meet, share experiences and network with local colleagues working in pathology in the North of England.